Actos Of Takeda Pharma Linked To Bladder Cancer

Jul. 11 | In June 2011, the FDA required a new safety label stating that “the use of Actos for more than one year may increase a person’s chance of bladder cancer”. The French Medicines Agency conducted a study of 155,000 patients over four years which revealed...